<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Research in Molecular Medicine</title>
<title_fa>Research in Molecular Medicine</title_fa>
<short_title>Res Mol Med (RMM)</short_title>
<subject>Medical Sciences</subject>
<web_url>http://rmm.mazums.ac.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2322-1348</journal_id_issn>
<journal_id_issn_online>2322-133X</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.29252/rmm</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1398</year>
	<month>2</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2019</year>
	<month>5</month>
	<day>1</day>
</pubdate>
<volume>7</volume>
<number>2</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Evaluation of IL-2 and IL-7 expression in patients with prostate cancer</title>
	<subject_fa>ژنتیک</subject_fa>
	<subject>Genetic</subject>
	<content_type_fa>پژوهشي</content_type_fa>
	<content_type>Research</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;strong&gt;Background: &lt;/strong&gt;Prostate cancer is a biologically heterogeneous disease which has become the fifth leading cause of cancer-related deaths in men worldwide. Interleukins (ILs) display required inflammation moderator. IL-2 and IL-7 play significant roles in regulating cancer-immune system interactions. So, the purpose of this investigation was to evaluate the expression level of IL-2 and IL-7 in prostate cancer patients and healthy subjects.&lt;br&gt;
&lt;strong&gt;Materials and&lt;/strong&gt; &lt;strong&gt;methods&lt;/strong&gt;: In this case-control study, expression of IL-2 and IL-7 was examined in peripheral blood of 40 prostate cancer patients and 40 healthy subjects by reverse transcription quantitative real-time polymerase chain reaction.&lt;br&gt;
&lt;strong&gt;Results:&lt;/strong&gt; Our findings showed that IL-7 has highly elevated expression in patients with prostate cancer compared to healthy subjects (p-value = 0.0001). In contrast, no significant difference was observed in the expression of the IL-2 between the two study groups (p-value = 0.12).&lt;br&gt;
&lt;strong&gt;Conclusions:&lt;/strong&gt; Based on the results, IL-7 may be used as a prospective biomarker or as a molecular target in designing new prostate cancer control strategies. However, the findings of this investigation revealed no association between IL-2 expression and prostate cancer. Nevertheless, more studies should be included to appraise the exact relevance of this gene to prostate cancer.</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Interleukin, IL-2, IL-7, Prostate cancer.</keyword>
	<start_page>33</start_page>
	<end_page>38</end_page>
	<web_url>http://rmm.mazums.ac.ir/browse.php?a_code=A-10-1098-3&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Faezeh</first_name>
	<middle_name></middle_name>
	<last_name>Namazi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>faezehnamazi@yahoo.com</email>
	<code>10031947532846008579</code>
	<orcid>10031947532846008579</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Medical Biotechnology Research Center, Ashkezar Branch, Islamic Azad University, Ashkezar, Yazd, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Nasrin</first_name>
	<middle_name></middle_name>
	<last_name>Hadi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>nasrinhadi90@gmail.com</email>
	<code>10031947532846008580</code>
	<orcid>10031947532846008580</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Medical Genetics Research Center of Genome, Mohtasham St., Isfahan, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Fatemeh</first_name>
	<middle_name></middle_name>
	<last_name>Parnian</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>Fparnian.fp@gmail.com</email>
	<code>10031947532846008581</code>
	<orcid>10031947532846008581</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Medical Biotechnology, International Campus,  Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Mansour</first_name>
	<middle_name></middle_name>
	<last_name>Moghimi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>mansour_moghimi@yahoo.com</email>
	<code>10031947532846008582</code>
	<orcid>10031947532846008582</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Associate Professor of Clinical and Surgical pathology, Department of Pathology, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
